These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26611146)

  • 21. The identification of immune genes in the milk transcriptome of the Tasmanian devil (Sarcophilus harrisii).
    Hewavisenti RV; Morris KM; O'Meally D; Cheng Y; Papenfuss AT; Belov K
    PeerJ; 2016; 4():e1569. PubMed ID: 26793426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
    Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM
    Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
    Deakin JE; Belov K
    Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
    Hollings T; Jones M; Mooney N; McCallum H
    Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the devil facial tumour produce immunosuppressive cytokines as an immune evasion strategy?
    Morris K; Belov K
    Vet Immunol Immunopathol; 2013 May; 153(1-2):159-64. PubMed ID: 23465357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of non-classical MHC class I genes in the Tasmanian devil (Sarcophilus harrisii).
    Cheng Y; Belov K
    Immunogenetics; 2014 Dec; 66(12):727-35. PubMed ID: 25267059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of CORE-SINEs in the genome of the Tasmanian devil.
    Nilsson MA; Janke A; Murchison EP; Ning Z; Hallström BM
    BMC Genomics; 2012 May; 13():172. PubMed ID: 22559330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii).
    Jones EA; Cheng Y; O'Meally D; Belov K
    Immunogenetics; 2017 Mar; 69(3):133-143. PubMed ID: 27838759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
    Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
    Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptospirosis in Tasmanian Devils ( Sarcophilus harrisii ) in Tasmania, 2008-12.
    Wynwood SJ; Burns MA; Graham GC; Weier SL; McKay DB; Peck S; Craig SB
    J Wildl Dis; 2016 Jul; 52(3):636-41. PubMed ID: 27243149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
    Peel E; Belov K
    Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
    Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.
    Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB; Woods GM
    Dev Comp Immunol; 2015 Nov; 53(1):123-33. PubMed ID: 26182986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic insights into a contagious cancer in Tasmanian devils.
    Grueber CE; Peel E; Gooley R; Belov K
    Trends Genet; 2015 Sep; 31(9):528-35. PubMed ID: 26027792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.
    Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB
    Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
    Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.